Teva Jumps as CEO Seeks Profit in Brand Drugs

Teva Jumps as CEO Seeks Profit in Brand Drugs

Adam Reynolds/Bloomberg

A logo is displayed at the entrance to Teva Pharmaceutical Industries Ltd.'s headquarters in Jerusalem. The Israeli company bought Frazer, Pennsylvania-based Cephalon Inc. last year in a bid to broaden its portfolio of brand-name treatments.